Experimental Pfizer pill prevents Covid hospitalizations and deaths
An experimental antiviral pill developed by Pfizer reduced the risk of death and hospitalization by 89% in patients who were newly diagnosed with Covid-19 in a large study, the company said Friday.
The development of oral medicines that can be used to treat Covid early on could blunt the impact of the pandemic.
Read Original Article: Experimental Pfizer pill prevents Covid hospitalizations and deaths »
